Intervention Protocol

Anti-depressants and centrally active agents for fibromyalgia syndrome

  1. María Betina Nishishinya1,*,
  2. Brian Walitt2,
  3. Gerard Urrútia3,
  4. Philip J Mease4,
  5. Alexis Rodríguez5,
  6. Ricardo J Riera Lizardo6,
  7. Luis Ernesto González7,
  8. Godwin Darko8

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD006192

Database Title

Additional Information

How to Cite

Nishishinya MB, Walitt B, Urrútia G, Mease PJ, Rodríguez A, Riera Lizardo RJ, González LE, Darko G. Anti-depressants and centrally active agents for fibromyalgia syndrome (Protocol). Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD006192. DOI: 10.1002/14651858.CD006192.

Author Information

  1. 1

    Institute of Biomedical Research (IIB Sant Pau), Iberoamerican Cochrane Centre, Barcelona, Spain

  2. 2

    Washington Hospital Center, Georgetown University Medical Center, Washington, DC, USA

  3. 3

    CIBER Epidemiología y Salud Pública (CIBERESP), Spain, Iberoamerican Cochrane Centre - IIB Sant Pau, Barcelona, Spain

  4. 4

    Swedish Hospital Medical Center, Rheumatology Clinical Research, Seattle, USA

  5. 5

    Hospital de la Vall d'Hebron, Servei de Farmacologia, Barcelona, Spain

  6. 6

    Universidad de Carabobo, Medicine Department, Rheumatology Unit, Valencia, Venezuela

  7. 7

    Universidad Tecnológica Equinoccial, Facultad de Ciencias de la Salud Eugenio Espejo, Quito, Ecuador

  8. 8

    Washington Hospital Center, Department of Medicine, Washington, DC, USA

*María Betina Nishishinya, Iberoamerican Cochrane Centre, Institute of Biomedical Research (IIB Sant Pau), Ed. Casa de Convalescència, Sant Antoni M. Claret 171 4 planta, Barcelona, E - 08041, Spain. betinanishishinya@yahoo.es. mnishishinya@santpau.es.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (128K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective is to assess the efficacy and safety of anti-depressants and centrally active agents in the treatment of fibromyalgia syndrome.

View Full Article (HTML) Full (128K)